The mean STS score was 2.0% in the TAVI arm and 1.9% in the surgery group. Patients were implanted with CoreValve, Evolut R, or Evolut PRO (n = 730; Medtronic) or underwent surgery with a ...

In patients with symptomatic severe aortic stenosis at intermediate or higher surgical risk, CoreValve or Evolut transcatheter aortic valve implantation (TAVI) was associated with a lower 5-year ...